Conventional eye drop bottles are inaccurate, ineffective and inconvenient. People suffering from severe, chronic eye conditions have for too long been forced to accept an unsatisfactory treatment paradigm. That is why we invented MistGo.
MistGo is a truly revolutionary ophthalmic drug administration system. It is the first eye care technology to consistently secure the right dose and the right delivery into the cornea of the eye for full exploitation of the drug and optimal treatment effect. On top, MistGo is extremely easy and comfortable to use whether you are young or senior, at home or on the go.
MistGo creates an exceptional experience that motivates people with an eye disease to complete their treatment. Higher patient compliance translates into improved eye health and life quality.
This superior performing technology is compatible with any ocular liquid, also preservative free that can be atomized. Leading ophthalmologist and frontrunning industry players have already named MistGo “a true game changer in eye care”.
Conventional eye drop bottles are inaccurate, ineffective and inconvenient. People suffering from severe, chronic eye conditions have for too long been forced to accept an unsatisfactory treatment paradigm. That is why we invented MistGo.
MistGo is a truly revolutionary ophthalmic drug administration system. It is the first eye care technology to consistently secure the right dose and the right delivery into the cornea of the eye for full exploitation of the drug and optimal treatment effect. On top, MistGo is extremely easy and comfortable to use whether you are young or senior, at home or on the go.
MistGo creates an exceptional experience that motivates people with an eye disease to complete their treatment. Higher patient compliance translates into improved eye health and life quality.
This superior performing technology is compatible with any ocular liquid, also preservative free that can be atomized. Leading ophthalmologist and frontrunning industry players have already named MistGo “a true game changer in eye care”.
An eye aiming interface makes it easy to accurately and precisely instill the mist into the cornea without having to tilt the head in an unnatural position or to accidentally touch the eye with the device.
The internal geometry of the nozzle is optimized to vaporize the liquid into a fine mist, which feels comfortable and soothing in the eye compared to a single, dense drop.
A two-step intuitive activation procedure is designed to enable users with reduced strength in their hands to easily load and release the mist. This is particularly an advantage to seniors and children.
Mechanically compressed air is used to propel and gently deliver the complete dose into the cornea, before the eye can even make a blink.
An airtight cartridge contains the preservative free liquid to ensure its durability for minimum 6 months from the moment the device has been put into use. A smart indicator on the back of the device shows the level of liquid left, so you know when it is time to restock.
MistGo targets people of all ages suffering from severe and chronic eye conditions such as dry eye disease (DED), glaucoma and allergies. When left untreated or not treated correctly, these eye conditions all result in deteriorating eye health, worst case in blindness, and reduced life quality for the individual. This again bears significant costs to health economies and society at large.
MistGo offers people dependent on eye medication an easy way to treat their eye condition optimallly for best therapeutic effect. The effectiveness of MistGo even makes it cost competitive globally to the conventional eye drop bottle, and it allows the ophthalmic industry to optimize the level of active ingredients and introduce novel ocular medication for entirely new treatment possibilities. That is good news for the individual, for society and for business.
At EYE-GO, we care for the planet and the people living on it. By enhancing the lives of people suffering from chronic eye conditions, we also improve the resource efficiency of ocular drug production. When applying MistGo as your ophthalmic drug administration system, no liquid is wasted meaning less carbon emission per treatment to the benefit of the environment.
All components inside MistGo is made of recyclable materials. Under current regulations, we are unfortunately not able to exploit the opportunity to recycle the components. In the meantime, it is worth noting that the same amount of recyclable plastic is used per treatment with MistGo as with conventional drop bottles for eye care.
EYE-GO is a Danish-based MedTech start-up developing disruptive eye care technologies that improve the quality of life of people around the world suffering from severe and chronic eye conditions, such as dry eye disease (DED), glaucoma and allergies.
At EYE-GO, we work with some of the most esteemed experts and research institutions in the Scandinavian ophthalmic space. Our own team has extensive experience with customer centric product design and with bringing products from idea to market in the fastest and most efficient way. The board of directors, comprising strong business leaders and professional investors, contribute with many years of MedTech and venture capital experience.
EYE-GO A/S was established in 2015 and has already attracted significant funding. The circle of owners includes business angles, Maj Invest, and recently also Vækstfonden and Innovationsfonden, both owned by the Danish state.
In an effort to secure greater strategic focus and even better execution of the strategy, it has been decided to make changes in key organizational positions at EYE-GO. As of October 2018, chairman Jesper Boysen and board member Henrik E. Wulff will step out of the board. Instead former board member Christian Stig Møller has been constituted as new chairman.
At the same time, the new board of directors has decided to appoint Henrik Nagel as new CEO of EYE-GO. Henrik comes with more than 25 years of international management experience from world-leading tech companies mainly within life science. He is the perfect candidate to secure the future continued success of EYE-GO.
To further strengthen our commercial muscle and accelerate activities even further Louise von Haffner will join our team as Director of Business Development as of October 1st. With her strong track record of translating tech solutions into compelling value propositions and of bringing wining go2market strategies to life, we are certain Louise will be a great asset to our team.
At the same time we staff-up in the area of RA and QA. To secure a strategic approach to RA and QA as well as handle the dialogue with relevant regulatory bodies going forward, Sten Elkjær Andersen will join our team as Director of RA & QA also as of October 1st. Sten has worked within the medico industry his entire professional career amongst others as Director of RA & QA at Ambu A/S. With Sten on board we are equipped best possible to continue to comply with and develop in line with regulatory requirements
